Expression of vegf and ngf in gliomas of human

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 3, 2009, Pages 408-411

  Li, Jing Tao ^a   Yan, Qi ^a   Yu, Hua Lin ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Immunohistochemistry; NGF gliomas; VEGF; Western blot

Indexed keywords

EID: 67649979734     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. J Urol, 1997;157 (2) :323-328.
2. Wong AK, Alfert M. Castrillon DH, et al. Excessive tumorelaborated VEGF and its neutralization define a lethal paraneoplastic syndrome. Proc Natl Acad Sci USA, 2001; 98 (13) :7481-7486.
3. Kruttgen A. Schneider I. Weis J. The dark side of the NGF family: neurotrophins in neoplasias. Brain Patho, 2006; 16 (4) : 304-310.
4. Dolle L. Adriaenssens E. El Yazidi-Belkoura I, et al. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets, 2004;4 (6) :463-470.
5. Davidson B. Reich R. Lazarovici P. et al. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat, 2004; 83 (2) : 119-128.
6. Stroinberg I. Chromaffin grafts: survival nerve fiber formation as a function of donorage, nerve growth factor and host sympathetic denervation. Prog Brain Res, 1990;82:87-94.
7. Sasaki M. Wizigmann VS, Risan W. et al. Retovirus producer cell encoding antisense VEGF prolong survival of rat with intracranial BG9L glioma. Int J Dev Neurasic, 1999;17 (5-6) : 579-591.
8. Och W. Mariak Z. Smolka'M, et al. Vascular endothelial growth factor expression in cerebral neoplasms. Neurol Neurochir Pol, 2001;35 (6) :1071-1079.
9. Wood PA, Bove K. You S. et al. Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther, 2005;4 (7) : 1065-1075.
10. Steiner HH, Karcher S. Mueller MM, et al. Autocrine pathways of the vascular endothelial growth factor (VEGF) in glioblastoma multiforme; clinical relevance of radiation-induced increase of VEGF levels. J Neurooncol, 2004; 66 (1-2) : 129-138.
11. Chinise source
12. Frade JM, Rodriguez Tebar A. Barde YA. Induction of cell death by endogenous NGF through its P75 receptor. Nature, 1996;383 (6596) :166-168.
13. Chinise source
14. Chinise source
15. Chinise source
16. Singer HS, Hansen B. Martinie D. et al. Mitogensis in glioblastoma multforme cell lines: a role for NGF and its TrkA receptors. J Neurooncol, 1999;45 (1) :1-8.
17. Chinise source
18. Denkins Y. Reiland J. Roy M. Brain metastases in melanoma, roles of neurotrophins. Neuro Oncol, 2004, (2) :154-165.
19. Dolle L. El Yazidi-Belkoura I, Adriaenssens E. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene, 2003; 22 (36) : 5592-5601.
20. Jing S. Tapley P. Barbacid M. Nerve growth factormediates signal transduction through trk homodimer receptors. Neuron, 1992; 9 (6) :1067-1079.
21. Descamps S. Toillon RA, Adriaenssens E. et al. Nerve growth factor stimulates proliferation and survival ofhuman breastcancer cells through two distinct signaling pathways. J Biol Chem, 2001: 276 (21) ;17864-17870.
22. Chinise source
23. Guan M. Yam HF, Su B. et al. Loss of pigment epithelium derived factor expression in glioma progression. J Clin Patho, 2003, 56 (4), 277-282.